Annual Cash & Cash Equivalents
$31.02 M
+$15.74 M+102.98%
31 December 2023
Summary:
AxoGen annual cash & cash equivalents is currently $31.02 million, with the most recent change of +$15.74 million (+102.98%) on 31 December 2023. During the last 3 years, it has fallen by -$1.73 million (-5.29%). AXGN annual cash & cash equivalents is now -36.38% below its all-time high of $48.77 million, reached on 31 December 2020.AXGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$18.66 M
-$527.00 K-2.75%
30 September 2024
Summary:
AxoGen quarterly cash and cash equivalents is currently $18.66 million, with the most recent change of -$527.00 thousand (-2.75%) on 30 September 2024. Over the past year, it has dropped by -$12.36 million (-39.85%). AXGN quarterly cash and cash equivalents is now -86.03% below its all-time high of $133.56 million, reached on 30 June 2018.AXGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXGN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -39.9% |
| 3 y3 years | -5.3% | -43.0% |
| 5 y5 years | -13.2% | -47.8% |
AXGN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.3% | +103.0% | -43.0% | +142.1% |
| 5 y | 5 years | -36.4% | +103.0% | -75.2% | +142.1% |
| alltime | all time | -36.4% | >+9999.0% | -86.0% | >+9999.0% |
AxoGen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.66 M(-2.7%) |
| June 2024 | - | $19.19 M(+22.1%) |
| Mar 2024 | - | $15.71 M(-49.4%) |
| Dec 2023 | $31.02 M(+103.0%) | $31.02 M(-0.2%) |
| Sept 2023 | - | $31.09 M(+33.9%) |
| June 2023 | - | $23.22 M(+201.3%) |
| Mar 2023 | - | $7.71 M(-49.6%) |
| Dec 2022 | $15.28 M(-53.3%) | $15.28 M(+6.7%) |
| Sept 2022 | - | $14.32 M(+21.1%) |
| June 2022 | - | $11.82 M(-18.8%) |
| Mar 2022 | - | $14.56 M(-55.6%) |
| Dec 2021 | $32.76 M(-32.8%) | $32.76 M(-29.9%) |
| Sept 2021 | - | $46.73 M(-12.0%) |
| June 2021 | - | $53.08 M(+33.2%) |
| Mar 2021 | - | $39.84 M(-18.3%) |
| Dec 2020 | $48.77 M(+36.5%) | $48.77 M(-18.7%) |
| Sept 2020 | - | $60.00 M(-20.3%) |
| June 2020 | - | $75.32 M(+109.8%) |
| Mar 2020 | - | $35.89 M(+0.5%) |
| Dec 2019 | $35.72 M(+47.0%) | $35.72 M(+45.5%) |
| Sept 2019 | - | $24.55 M(-1.3%) |
| June 2019 | - | $24.88 M(+5.8%) |
| Mar 2019 | - | $23.52 M(-3.2%) |
| Dec 2018 | $24.29 M(-33.5%) | $24.29 M(-5.2%) |
| Sept 2018 | - | $25.63 M(-80.8%) |
| June 2018 | - | $133.56 M(+337.1%) |
| Mar 2018 | - | $30.56 M(-16.3%) |
| Dec 2017 | $36.51 M(+21.6%) | $36.51 M(+65.6%) |
| Sept 2017 | - | $22.04 M(-7.7%) |
| June 2017 | - | $23.87 M(-7.9%) |
| Mar 2017 | - | $25.91 M(-13.7%) |
| Dec 2016 | $30.01 M(+15.8%) | $30.01 M(+87.6%) |
| Sept 2016 | - | $16.00 M(-12.4%) |
| June 2016 | - | $18.27 M(-12.8%) |
| Mar 2016 | - | $20.95 M(-19.1%) |
| Dec 2015 | $25.91 M(+215.4%) | $25.91 M(-13.4%) |
| Sept 2015 | - | $29.94 M(+91.6%) |
| June 2015 | - | $15.62 M(-18.9%) |
| Mar 2015 | - | $19.26 M(+134.4%) |
| Dec 2014 | $8.22 M(-59.1%) | $8.22 M(-30.4%) |
| Sept 2014 | - | $11.80 M(-16.7%) |
| June 2014 | - | $14.17 M(-15.7%) |
| Mar 2014 | - | $16.81 M(-16.3%) |
| Dec 2013 | $20.07 M(+44.3%) | $20.07 M(-11.1%) |
| Sept 2013 | - | $22.59 M(+159.8%) |
| June 2013 | - | $8.69 M(-22.4%) |
| Mar 2013 | - | $11.20 M(-19.5%) |
| Dec 2012 | $13.91 M(+69.8%) | $13.91 M(+212.9%) |
| Sept 2012 | - | $4.45 M(-4.2%) |
| June 2012 | - | $4.64 M(-17.8%) |
| Mar 2012 | - | $5.64 M(-31.1%) |
| Dec 2011 | $8.19 M(+355.3%) | $8.19 M(-22.2%) |
| Sept 2011 | - | $10.53 M(+10.2%) |
| June 2011 | - | $9.56 M(+69.4%) |
| Mar 2011 | - | $5.64 M(+213.6%) |
| Dec 2010 | $1.80 M(-88.6%) | $1.80 M(-80.6%) |
| Sept 2010 | - | $9.28 M(-3.6%) |
| June 2010 | - | $9.63 M(-5.4%) |
| Mar 2010 | - | $10.18 M(-35.4%) |
| Dec 2009 | $15.77 M(+4637.4%) | $15.77 M(+6830.2%) |
| Sept 2009 | - | $227.50 K(+7.7%) |
| June 2009 | - | $211.20 K(-12.8%) |
| Mar 2009 | - | $242.30 K(-27.2%) |
| Dec 2008 | $332.80 K(-60.0%) | $332.80 K(-18.8%) |
| Sept 2008 | - | $410.10 K(-30.3%) |
| June 2008 | - | $588.60 K(-27.2%) |
| Mar 2008 | - | $808.90 K(-2.9%) |
| Dec 2007 | $832.90 K(-35.0%) | $832.90 K(-11.7%) |
| Sept 2007 | - | $943.40 K(-10.5%) |
| June 2007 | - | $1.05 M(-14.2%) |
| Mar 2007 | - | $1.23 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $1.28 M(-2.2%) | $1.28 M(-5.9%) |
| Sept 2006 | - | $1.36 M(-5.8%) |
| June 2006 | - | $1.45 M(+1.1%) |
| Mar 2006 | - | $1.43 M(+9.1%) |
| Dec 2005 | $1.31 M(-41.5%) | $1.31 M(-3.3%) |
| Sept 2005 | - | $1.35 M(-8.3%) |
| June 2005 | - | $1.48 M(-4.8%) |
| Mar 2005 | - | $1.55 M(-30.7%) |
| Dec 2004 | $2.24 M(+362.9%) | $2.24 M(+6.1%) |
| Sept 2004 | - | $2.11 M(+136.7%) |
| June 2004 | - | $891.60 K(+21.6%) |
| Mar 2004 | - | $733.50 K(+51.6%) |
| Dec 2003 | $483.80 K(-28.0%) | $483.80 K(+32.1%) |
| Sept 2003 | - | $366.20 K(-11.0%) |
| June 2003 | - | $411.30 K(+3.5%) |
| Mar 2003 | - | $397.20 K(-40.9%) |
| Dec 2002 | $671.60 K(-52.9%) | $671.60 K(+25.1%) |
| Sept 2002 | - | $537.00 K(-20.1%) |
| June 2002 | - | $672.00 K(+72.7%) |
| Mar 2002 | - | $389.10 K(-80.0%) |
| Dec 2001 | $1.43 M(-57.8%) | - |
| Sept 2001 | - | $1.94 M(-42.5%) |
| June 2001 | $3.38 M(+3270.3%) | $3.38 M(+6877.3%) |
| Mar 2001 | - | $48.40 K(-83.1%) |
| Dec 2000 | - | $285.60 K(+305.7%) |
| Sept 2000 | - | $70.40 K(-29.7%) |
| June 2000 | $100.20 K(-90.0%) | $100.20 K(+179.1%) |
| Mar 2000 | - | $35.90 K(-92.8%) |
| Sept 1999 | - | $500.00 K(-50.0%) |
| June 1999 | $1.00 M(-54.5%) | $1.00 M(+11.1%) |
| Mar 1999 | - | $900.00 K(-10.0%) |
| Dec 1998 | - | $1.00 M(-50.0%) |
| Sept 1998 | - | $2.00 M(-9.1%) |
| June 1998 | $2.20 M(+214.3%) | $2.20 M(+37.5%) |
| Mar 1998 | - | $1.60 M(0.0%) |
| Dec 1997 | - | $1.60 M(+166.7%) |
| Sept 1997 | - | $600.00 K(-14.3%) |
| June 1997 | $700.00 K(-12.5%) | $700.00 K(+40.0%) |
| Mar 1997 | - | $500.00 K(-16.7%) |
| Dec 1996 | - | $600.00 K(+50.0%) |
| Sept 1996 | - | $400.00 K(-50.0%) |
| June 1996 | $800.00 K(0.0%) | $800.00 K(+300.0%) |
| Mar 1996 | - | $200.00 K(-60.0%) |
| Dec 1995 | - | $500.00 K(+25.0%) |
| Sept 1995 | - | $400.00 K(-50.0%) |
| June 1995 | $800.00 K(0.0%) | $800.00 K(+14.3%) |
| Mar 1995 | - | $700.00 K(-12.5%) |
| Dec 1994 | - | $800.00 K(+100.0%) |
| Sept 1994 | - | $400.00 K(-50.0%) |
| June 1994 | $800.00 K(+100.0%) | $800.00 K(+100.0%) |
| Mar 1994 | - | $400.00 K(+300.0%) |
| Dec 1993 | - | $100.00 K(-75.0%) |
| Sept 1993 | - | $400.00 K(0.0%) |
| June 1993 | $400.00 K(-73.3%) | $400.00 K(-50.0%) |
| Mar 1993 | - | $800.00 K(+300.0%) |
| Dec 1992 | - | $200.00 K(-50.0%) |
| Sept 1992 | - | $400.00 K(-73.3%) |
| June 1992 | $1.50 M(+200.0%) | $1.50 M(+150.0%) |
| Mar 1992 | - | $600.00 K(+500.0%) |
| Dec 1991 | - | $100.00 K(-66.7%) |
| Sept 1991 | - | $300.00 K(-40.0%) |
| June 1991 | $500.00 K(-16.7%) | $500.00 K(+25.0%) |
| Mar 1991 | - | $400.00 K(-20.0%) |
| Dec 1990 | - | $500.00 K(-28.6%) |
| Sept 1990 | - | $700.00 K(+16.7%) |
| June 1990 | $600.00 K(-50.0%) | $600.00 K(-40.0%) |
| Mar 1990 | - | $1.00 M(-9.1%) |
| Dec 1989 | - | $1.10 M(0.0%) |
| Sept 1989 | - | $1.10 M(-8.3%) |
| June 1989 | $1.20 M(+50.0%) | $1.20 M(+50.0%) |
| June 1988 | $800.00 K(-20.0%) | $800.00 K(-20.0%) |
| June 1987 | $1.00 M | $1.00 M |
FAQ
- What is AxoGen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AxoGen?
- What is AxoGen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AxoGen?
- What is AxoGen quarterly cash and cash equivalents year-on-year change?
What is AxoGen annual cash & cash equivalents?
The current annual cash & cash equivalents of AXGN is $31.02 M
What is the all time high annual cash & cash equivalents for AxoGen?
AxoGen all-time high annual cash & cash equivalents is $48.77 M
What is AxoGen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AXGN is $18.66 M
What is the all time high quarterly cash and cash equivalents for AxoGen?
AxoGen all-time high quarterly cash and cash equivalents is $133.56 M
What is AxoGen quarterly cash and cash equivalents year-on-year change?
Over the past year, AXGN quarterly cash and cash equivalents has changed by -$12.36 M (-39.85%)